Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy
Jeffrey Graham, J. Connor Wells, Shaan Dudani, Chun Loo Gan, Frede Donskov, Jae‐Lyun Lee, Christian Kollmannsberger, Luís Meza, Benoit Beuselinck, Aaron R. Hansen, Scott North, Georg A. Bjarnason, Nicolas Sayegh, Ravindran Kanesvaran, Lori Wood, Sébastien J. Hotte, Rana R. McKay, Toni K. Choueiri, Daniel Y.C. Heng
Topics & Concepts
Renal cell carcinomaMedicineOncologyImmune checkpointInternal medicineNivolumabCancer researchImmunotherapyCancerRenal cell carcinoma treatmentBladder and Urothelial Cancer TreatmentsCancer Immunotherapy and Biomarkers